These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 8295461

  • 1. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
    Witsell DL, Weissler MC, Donovan MK, Howard JF, Martinkosky SJ.
    Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
    [Abstract] [Full Text] [Related]

  • 2. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
    Grillone GA, Blitzer A, Brin MF, Annino DJ, Saint-Hilaire MH.
    Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
    [Abstract] [Full Text] [Related]

  • 3. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO, Brøndbo K, Ganes T.
    Tidsskr Nor Laegeforen; 1993 Mar 10; 113(7):841-3. PubMed ID: 8480289
    [Abstract] [Full Text] [Related]

  • 4. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P, Murry T, Swenson M, Woodson GE.
    Laryngoscope; 1992 Apr 10; 102(4):400-6. PubMed ID: 1556889
    [Abstract] [Full Text] [Related]

  • 5. Abductor laryngeal dystonia: a series treated with botulinum toxin.
    Blitzer A, Brin MF, Stewart C, Aviv JE, Fahn S.
    Laryngoscope; 1992 Feb 10; 102(2):163-7. PubMed ID: 1738288
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP, Morrison MD.
    J Otolaryngol; 1994 Jun 10; 23(3):160-4. PubMed ID: 8064952
    [Abstract] [Full Text] [Related]

  • 7. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).
    Blitzer A, Brin MF, Fahn S, Lovelace RE.
    Laryngoscope; 1988 Feb 10; 98(2):193-7. PubMed ID: 3339931
    [Abstract] [Full Text] [Related]

  • 8. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ.
    J Otolaryngol; 1996 Apr 10; 25(2):66-74. PubMed ID: 8683655
    [Abstract] [Full Text] [Related]

  • 9. Increased stability of airflow following botulinum toxin injection.
    Finnegan EM, Luschei ES, Gordon JD, Barkmeier JM, Hoffman HT.
    Laryngoscope; 1999 Aug 10; 109(8):1300-6. PubMed ID: 10443837
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S, Saeseow P, Taweesaengsuksakul R, Kharmwan S, Srirompotong S.
    J Med Assoc Thai; 2006 Dec 10; 89(12):2077-80. PubMed ID: 17214059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND, Wodchis WP, Spak C, Kileny PR.
    J Voice; 2001 Dec 10; 15(4):576-86. PubMed ID: 11792036
    [Abstract] [Full Text] [Related]

  • 13. Spasmodic dysphonia and laryngeal botulinum toxin injection.
    Smith ME.
    West J Med; 1993 Jul 10; 159(1):74. PubMed ID: 8351914
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG, Hunt EJ, Irish JC, Charles DA, Lang AE, Durkin LC, Wong DL.
    J Otolaryngol; 1995 Dec 10; 24(6):345-51. PubMed ID: 8699600
    [Abstract] [Full Text] [Related]

  • 16. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC, DelGaudio JM, Hapner ER, Johns MM.
    Arch Otolaryngol Head Neck Surg; 2005 Sep 10; 131(9):793-5. PubMed ID: 16172357
    [Abstract] [Full Text] [Related]

  • 17. "Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia.
    Haslinger B, Erhard P, Dresel C, Castrop F, Roettinger M, Ceballos-Baumann AO.
    Neurology; 2005 Nov 22; 65(10):1562-9. PubMed ID: 16301482
    [Abstract] [Full Text] [Related]

  • 18. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
    Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE.
    Mov Disord; 1989 Nov 22; 4(4):287-96. PubMed ID: 2811888
    [Abstract] [Full Text] [Related]

  • 19. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL, Irish JC, Adams SG, Durkin LC, Hunt EJ.
    J Otolaryngol; 1995 Feb 22; 24(1):64-8. PubMed ID: 7769649
    [Abstract] [Full Text] [Related]

  • 20. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL, Adams SG, Irish JC, Durkin LC, Hunt EJ, Charlton MP.
    J Otolaryngol; 1995 Aug 22; 24(4):209-16. PubMed ID: 8551532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.